Our interdisciplinary team of scientists collaborates to develop nanovaccines and nanotherapeutics
We are developing a universal influenza nanovaccine that would be effective against more strains of flu than current flu shots
For cancers, we are researching tumor-specific targets for nanotherapeutics
Nanovaccines can prevent tropical diseases such as malaria and filariasis
Nanotherapeutics use lower dosages than systemic drugs, allowing life-saving drugs to be used for young children
Nanoparticles can deliver therapeutic agents across the blood-brain barrier to treat neural disorders such as Alzheimer's, Parkinson's, and traumatic brain injury
Nanotechnologies can help optimize aging via improved biosensing capabilities and vaccine delivery
Researching veterinary diseases such as swine flu, avian flu, and bovine respiratory syncytial virus can help design nanovaccines to prevent similar diseases in humans
No needles, no boosters: extended-release nanovaccines can be delivered by nasal inhaler rather than injection
Nanovaccines don't need refrigeration (polio campaign worker in India carrying styrofoam cooler for vaccine)
Nanoparticles average only 300 nanometers in diameter, 1000 times smaller than the period at the end of a sentence.
Aerosol-printed graphene unveiled as low cost, faster food toxin sensor
Researchers have developed a graphene-based electrochemical sensor capable of detecting histamines (allergens) and toxins in food much faster than standard laboratory tests.
The team used … Read more
Zeteo Biomedical Intro- duces Nasal Vaccine and Drug Delivery Systems
Zeteo’s patient-centric delivery systems are designed for quick manufacturing to facilitate rapid deployment of drugs and vaccines to global populations
AUSTIN, TX – 14 May 2020 –(PR.com) – Zeteo … Read more
Link between liver and heart disease could lead to new therapeutics
A new study that looks closely at the cardiac health of flies provides new evidence that liver dysfunction may lead to deterioration of the heart.
The research fills in gaps in how scientists … Read more
SwRI awarded $1.9 million contract to develop treatment for COVID-19
Using Department of Defense supercomputers, Southwest Research Institute is virtually screening millions of drug compounds to search for and test possible treatment options for the novel coronavirus … Read more